The venture's focus on predicting drug resistance mutations from protein sequence alone aligns with the goals of Horizon Europe, which aims to support innovation and research in the EU. The programme's emphasis on competitiveness and funding for research and innovation makes it a strong fit for the venture. The venture's target geography, including the EU, also matches the programme's focus.